fingolimod hydrochloride has been researched along with Autoimmune Thyroiditis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshikawa, S; Ito, S; Mori, K; Morohoshi, K; Nakagawa, Y; Osone, M; Ozaki, H; Takahashi, Y; Yoshida, K | 1 |
| Fujimura, A; Hozumi, Y; Kobayashi, E; Miyata, M | 1 |
2 other study(ies) available for fingolimod hydrochloride and Autoimmune Thyroiditis
| Article | Year |
|---|---|
The sphingosine 1-phosphate receptor modulator FTY720 prevents iodide-induced autoimmune thyroiditis in non-obese diabetic mice.
Topics: Animals; Autoantibodies; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Female; Fingolimod Hydrochloride; Flow Cytometry; Forkhead Transcription Factors; Iodides; Lymphocyte Count; Male; Mice; Mice, Inbred NOD; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Thyroiditis, Autoimmune | 2011 |
Immunotherapy for experimental rat autoimmune thyroiditis using a novel immunosuppressant, FTY720.
Topics: Animals; Body Weight; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Liver; Organ Size; Propylene Glycols; Rats; Sphingosine; Spleen; Thyroid Gland; Thyroiditis, Autoimmune; Thyrotropin | 1999 |